MEDI6012

DB14833Investigational

Recombinant human lecithin:cholesterol acyltransferase is under investigation in clinical trial NCT03578809 (A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction).

Mechanism: Pharmacologically active on Phosphatidylcholine-sterol acyltransferase
Curator reviewed
Also known as: Recombinant human lecithin:cholesterol acyltransferase
Code names: ACP-501 · MEDI6012

Resolves to

Compound

UNIIXBA7E67HMJ

Targets

P04180LCAT

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with MEDI6012, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account